• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吗啡与可乐定对小鼠胃肠道转运的相互作用。

Interaction of morphine and clonidine on gastrointestinal transit in mice.

作者信息

Puig M M, Pol O, Warner W

机构信息

Department of Anesthesiology, Hospital Universitario del Mar, IMIM, Barcelona, Spain.

出版信息

Anesthesiology. 1996 Dec;85(6):1403-12. doi: 10.1097/00000542-199612000-00022.

DOI:10.1097/00000542-199612000-00022
PMID:8968188
Abstract

BACKGROUND

Combinations of drugs are frequently used to achieve effective analgesia while minimizing side effects. Although the analgesic effects of morphine and clonidine seem to be synergistic, few studies have investigated other effects. Their role in inhibiting gastrointestinal transit was evaluated using different methods of analysis.

METHODS

Percentage inhibition of transit induced by morphine, clonidine, or their combination was measured in mice that had been given an intragastric charcoal meal. Dose-response curves were obtained for each drug individually; for morphine:clonidine at 1:3, 1:1, and 1:0.33 ratios; and for morphine in the presence of 0.0138 mg/kg clonidine. The interaction was evaluated by isobolograms, combination indexes, and fixed-dose analysis.

RESULTS

Each drug and their combinations inhibited transit in a dose-related manner. Combinations of morphine and clonidine produced interaction that depended on the ratio and level of response. The interaction analyzed by isobolograms and combination indexes showed that combinations in 1:1 and 1:3 proportions were synergistic at the median effective doses or less and were antagonistic at larger doses. Fixed-dose analysis using different ratios showed similar results. The effects of the combination (median effective dose at 1:1 ratio) were antagonized by efaroxan but not by naloxone, suggesting a predominant role of alpha-2-mediated effects.

CONCLUSIONS

Investigations into drug interactions should include several levels of response and combinations at different ratios. Isobolographic analysis permits the statistical evaluation of results without making assumptions about mechanisms of action of the drugs or their interactions. In this study, the combination of morphine and clonidine should produce synergy, antagonism, or no interaction depending on the relative doses and the level of effect.

摘要

背景

联合使用药物常用于在使副作用最小化的同时实现有效的镇痛效果。尽管吗啡和可乐定的镇痛作用似乎具有协同性,但很少有研究探究其他作用。使用不同的分析方法评估了它们在抑制胃肠转运方面的作用。

方法

在给予胃内炭末餐的小鼠中测量吗啡、可乐定或其组合诱导的转运抑制百分比。分别获得每种药物的剂量-反应曲线;吗啡与可乐定比例为1:3、1:1和1:0.33时的组合曲线;以及在存在0.0138mg/kg可乐定情况下吗啡的曲线。通过等效应线图、组合指数和固定剂量分析评估相互作用。

结果

每种药物及其组合均以剂量相关的方式抑制转运。吗啡和可乐定的组合产生的相互作用取决于比例和反应水平。通过等效应线图和组合指数分析的相互作用表明,1:1和1:3比例的组合在半数有效剂量及以下时具有协同作用,而在较大剂量时具有拮抗作用。使用不同比例的固定剂量分析显示了类似的结果。该组合(1:1比例时的半数有效剂量)的作用可被阿法罗定拮抗,但不能被纳洛酮拮抗,提示α-2介导的效应起主要作用。

结论

对药物相互作用的研究应包括几个反应水平和不同比例的组合。等效应线图分析允许对结果进行统计学评估,而无需对药物的作用机制或其相互作用做出假设。在本研究中,吗啡和可乐定的组合根据相对剂量和效应水平应产生协同、拮抗或无相互作用。

相似文献

1
Interaction of morphine and clonidine on gastrointestinal transit in mice.吗啡与可乐定对小鼠胃肠道转运的相互作用。
Anesthesiology. 1996 Dec;85(6):1403-12. doi: 10.1097/00000542-199612000-00022.
2
Intestinal inflammation and morphine tolerance alter the interaction between morphine and clonidine on gastrointestinal transit in mice.肠道炎症和吗啡耐受性会改变吗啡与可乐定在小鼠胃肠道转运方面的相互作用。
Anesthesiology. 2000 Jul;93(1):219-30. doi: 10.1097/00000542-200007000-00033.
3
Interaction between the inhibitory effects of morphine and clonidine on intestinal transit in mice.吗啡和可乐定对小鼠肠道转运的抑制作用之间的相互作用。
Methods Find Exp Clin Pharmacol. 1991 May;13(4):249-54.
4
Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.小鼠中阿片类药物与去甲肾上腺素能激动剂之间的脊髓相互作用:相乘作用涉及δ和α-2受体。
J Pharmacol Exp Ther. 1992 Jul;262(1):365-74.
5
Differential effects of clonidine and dexmedetomidine on gastric emptying and gastrointestinal transit in the rat.可乐定和右美托咪定对大鼠胃排空和胃肠转运的不同作用。
Br J Anaesth. 1997 Mar;78(3):301-7. doi: 10.1093/bja/78.3.301.
6
The effect of some alpha 2-adrenoceptor agonists and antagonists on gastrointestinal transit in mice: influence of morphine, castor oil and glucose.
Clin Exp Pharmacol Physiol. 1993 Jan;20(1):1-6. doi: 10.1111/j.1440-1681.1993.tb01495.x.
7
Interactions of clonidine and naloxone on schedule-controlled behavior in opioid-naive mice.可乐定与纳洛酮对阿片类未接触小鼠按程序控制行为的相互作用。
Psychopharmacology (Berl). 1989;98(4):445-7. doi: 10.1007/BF00441939.
8
Quinine-induced inhibition of gastrointestinal transit in mice: possible involvement of endogenous opioids.奎宁对小鼠胃肠道转运的抑制作用:内源性阿片类物质可能参与其中。
Eur J Pharmacol. 1999 Jan 8;364(2-3):193-7. doi: 10.1016/s0014-2999(98)00842-5.
9
Interactions between different antidepressants and morphine alter gastrointestinal transit in mice.不同抗抑郁药与吗啡之间的相互作用会改变小鼠的胃肠蠕动。
Life Sci. 1997;61(9):PL109-13. doi: 10.1016/s0024-3205(97)00595-x.
10
An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates.可乐定与阿片类药物全身及鞘内联合给药抗伤害感受作用的等高线分析
J Pharmacol Exp Ther. 1990 Dec;255(3):1107-16.

引用本文的文献

1
Sildenafil normalizes bowel transit in preclinical models of constipation.西地那非可使便秘临床前模型中的肠道转运恢复正常。
PLoS One. 2017 Apr 27;12(4):e0176673. doi: 10.1371/journal.pone.0176673. eCollection 2017.
2
Morphine and clonidine combination therapy improves therapeutic window in mice: synergy in antinociceptive but not in sedative or cardiovascular effects.吗啡与可乐定联合治疗可改善小鼠的治疗窗:在镇痛方面有协同作用,但在镇静或心血管效应方面无协同作用。
PLoS One. 2014 Oct 9;9(10):e109903. doi: 10.1371/journal.pone.0109903. eCollection 2014.
3
Antibodies and antisense oligodeoxynucleotides to mu-opioid receptors, selectively block the effects of mu-opioid agonists on intestinal transit and permeability in mice.
针对μ-阿片受体的抗体和反义寡脱氧核苷酸可选择性阻断μ-阿片激动剂对小鼠肠道转运和通透性的影响。
Br J Pharmacol. 1999 May;127(2):397-404. doi: 10.1038/sj.bjp.0702570.